Retrospective Diagnostic Accuracy Study of Abbott RealTi


Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
03 09 2021
Historique:
pubmed: 19 8 2021
medline: 30 12 2021
entrez: 18 8 2021
Statut: ppublish

Résumé

High-throughput centralized testing for tuberculosis (TB) and drug resistance is important, but comparative data are limited. In this retrospective cross-sectional study, participants were recruited from Johannesburg, South Africa, and Tbilisi, Georgia. The index tests, Abbott RealTi

Identifiants

pubmed: 34406811
doi: 10.1128/Spectrum.00132-21
pmc: PMC8552641
doi:

Substances chimiques

Antitubercular Agents 0
Isoniazid V83O1VOZ8L
Rifampin VJT6J7R4TR

Types de publication

Evaluation Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0013221

Références

N Engl J Med. 2010 Sep 9;363(11):1005-15
pubmed: 20825313
Eur Respir J. 2021 Feb 4;57(2):
pubmed: 32855226
J Clin Microbiol. 2018 Nov 27;56(12):
pubmed: 30305387
Cochrane Database Syst Rev. 2019 Jun 07;6:CD009593
pubmed: 31173647
Int J Infect Dis. 2020 Jun;95:246-252
pubmed: 32247825
Clin Infect Dis. 2011 Aug;53(4):369-72
pubmed: 21810750
Tuberculosis (Edinb). 2015 Sep;95(5):613-9
pubmed: 26119174
Sci Rep. 2018 Mar 26;8(1):5201
pubmed: 29581435
J Clin Microbiol. 2021 Feb 18;59(3):
pubmed: 33268535
Lancet Infect Dis. 2018 Jan;18(1):76-84
pubmed: 29198911
Tuberculosis (Edinb). 2017 May;104:65-69
pubmed: 28454651
J Clin Microbiol. 2017 Aug;55(8):2491-2501
pubmed: 28592547
PLoS Med. 2009 Sep;6(9):e1000150
pubmed: 20101802
Tuberculosis (Edinb). 2016 Dec;101:137-143
pubmed: 27865383
Cochrane Database Syst Rev. 2014 Jan 21;(1):CD009593
pubmed: 24448973
J Clin Microbiol. 2021 Mar 19;59(4):
pubmed: 33568463
Lancet. 2007 Jun 16;369(9578):2042-2049
pubmed: 17574096
Int J Tuberc Lung Dis. 2015 Feb;19(2):185-90
pubmed: 25574917
Int J Infect Dis. 2016 Apr;45:78-80
pubmed: 26948480

Auteurs

Patrick Howlett (P)

National Heart & Lung Institute, Imperial College Londongrid.7445.2, London, United Kingdom.

Pamela Nabeta (P)

Foundation for Innovative New Diagnosticsgrid.452485.a, Geneva, Switzerland.

Nestan Tukvadze (N)

Foundation for Innovative New Diagnosticsgrid.452485.a, Geneva, Switzerland.
Research Unit, National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.

Samuel G Schumacher (SG)

Foundation for Innovative New Diagnosticsgrid.452485.a, Geneva, Switzerland.

Claudia M Denkinger (CM)

Foundation for Innovative New Diagnosticsgrid.452485.a, Geneva, Switzerland.
Division of Tropical Medicine, Center for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH